Global Bronchoscopes Market to Surpass USD 27 Billion by 2026 due to Rising Incidences of Respiratory Diseases
|
By HospiMedica International staff writers Posted on 21 Feb 2022 |
|
The global bronchoscopes market is projected to grow at a CAGR of 7.48% from USD 17.89 billion in 2020 to USD 27.48 billion by 2026, driven by the rising prevalence of various respiratory diseases such as tuberculosis, growing prevalence of lung cancers, increasing cases of chronic obstructive pulmonary diseases, and increasing product development activities in the bronchoscopes arena.
These are the latest findings of DelveInsight (New Delhi, India), a market research firm.
A bronchoscope is a device that is used in the visualization of the internal anatomy of the lungs. It's usually performed by a doctor who specializes in lung disorders (a pulmonologist). Bronchoscopy is a procedure where a thin tube is passed through the nose or mouth, down the throat, and then into the lungs.
The bronchoscopes market is witnessing positive growth owing to the rising prevalence of various respiratory diseases such as COVID-19 and lung cancers, increasing pneumonia cases in children, and increasing product development activities with respect to bronchoscopes, among others. Furthermore, high disposable income, sophisticated healthcare infrastructure, and increased awareness regarding disease progression and new treatments are also expected to aid the growth of the bronchoscopes market.
In addition to that, technological advancements in the field of bronchoscopies such as the development of new bronchoscopic techniques such as autofluorescence bronchoscopy (AFB) and high magnification broncho-videos copy (HMB), among others with the aim to enhance the yield and diagnostic accuracy are also expected to fuel market growth.
Moreover, the impact of the COVID-19 pandemic on the bronchoscopes market was neutral. Many major organizations across the world issued guidelines regarding the conducting of bronchoscopy in patients with respiratory illnesses. Bronchoscopy was contraindicated in patients with a positive COVID-19 test result due to the generation of aerosols during bronchoscopy which can put other patients and healthcare workers at risk. However, bronchoscopy was deemed an essential procedure in the event of complications such as atelectasis or hemoptysis, issues with mechanical ventilation, and to rule out complications associated with COVID-19.
Geographically, North America currently holds the largest share of the global bronchoscopes market and is expected to maintain its dominant position due to the rising prevalence of chronic obstructive pulmonary diseases and various cancers, including lung cancers, increased government initiatives, and more product launches in the region.
Related Links:
DelveInsight
Latest Business News
- GE HealthCare Leads Major European Initiative to Advance Cardio-Oncology Care
- Medtronic and GE HealthCare Broaden Alliance Across Monitoring and Care Solutions
- Quantum Surgical Acquires NeuWave from Johnson & Johnson
- Medtronic to Acquire Coronary Artery Medtech Company CathWorks
- Medtronic and Mindray Expand Strategic Partnership to Ambulatory Surgery Centers in the U.S.
- FDA Clearance Expands Robotic Options for Minimally Invasive Heart Surgery
- WHX in Dubai (formerly Arab Health) to debut specialised Biotech & Life Sciences Zone as sector growth accelerates globally
- WHX in Dubai (formerly Arab Health) to bring together key UAE government entities during the groundbreaking 2026 edition
- Interoperability Push Fuels Surge in Healthcare IT Market
- Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies
- B. Braun Acquires Digital Microsurgery Company True Digital Surgery
- CMEF 2025 to Promote Holistic and High-Quality Development of Medical and Health Industry
- Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies
- Medtronic Partners with Corsano to Expand Acute Care & Monitoring Portfolio in Europe
- Expanded Collaboration to Transform OR Technology Through AI and Automation
- Becton Dickinson to Spin Out Biosciences and Diagnostic Solutions Business
Channels
Artificial Intelligence
view channel
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read more
New AI Approach Monitors Brain Health Using Passive Wearable Data
Brain health spans cognitive and emotional functions and can fluctuate even in adults without diagnosed disease. Detecting early changes remains difficult in routine care and burdens specialty services... Read more
Critical Care
view channel
Automated IV Labeling Solution Improves Infusion Safety and Efficiency
Medication administration in high-acuity settings is often complicated by multiple concurrent infusions, making accurate line identification essential. In a 10-hospital intensive care unit study, 60% of... Read more
First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
Pulmonary hypertension is a progressive, life‑threatening disease that is frequently missed early because symptoms such as dyspnea are nonspecific and diagnostic delays can exceed two years.... Read more
Surgical Techniques
view channel
Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
Postoperative hypoxemia on general surgical wards is common and often missed by intermittent vital sign checks. Undetected low oxygen levels can delay recovery and raise the risk of complications that... Read more
New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
Volumetric muscle loss is a traumatic loss of skeletal muscle that often leads to permanent functional impairment and limited reconstructive options. Current experimental strategies struggle to deliver... Read more
Patient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Health IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
